Excelsior Biopharma Inc. (TPEX:6496)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.85
+0.05 (0.17%)
Jan 22, 2026, 1:30 PM CST

Excelsior Biopharma Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
54.51240.08589.92895.281,1031,141
Upgrade
Short-Term Investments
11.4511.45-211.19-11.01
Upgrade
Cash & Short-Term Investments
65.95251.53589.921,1061,1031,152
Upgrade
Cash Growth
-79.82%-57.36%-46.68%0.34%-4.25%229.62%
Upgrade
Accounts Receivable
178.38187.49160.53135.03213.06179.47
Upgrade
Other Receivables
1.851.212.192.951.4610.59
Upgrade
Receivables
180.23188.71162.73137.98214.51190.07
Upgrade
Inventory
318.63302.93217.28188.58204.6276.48
Upgrade
Other Current Assets
22.8430.5414.1710.0910.814.7
Upgrade
Total Current Assets
587.65773.7984.091,4431,5331,623
Upgrade
Property, Plant & Equipment
391.01431.86445.91164.61188.08214.31
Upgrade
Long-Term Investments
94.3196.468.1869.4474.1423.54
Upgrade
Other Intangible Assets
0.020.030.040.060.070.08
Upgrade
Long-Term Deferred Tax Assets
19.9419.9420.0520.1621.2318.32
Upgrade
Other Long-Term Assets
270.19256.4259.0417.5922.8421.04
Upgrade
Total Assets
1,3631,5781,5771,7151,8391,900
Upgrade
Accounts Payable
61.5192.5645.4263.75121.51128.85
Upgrade
Accrued Expenses
5.24.914.43.992.342.34
Upgrade
Current Portion of Long-Term Debt
---297.45--
Upgrade
Current Portion of Leases
50.4755.0253.9710.7513.712.64
Upgrade
Current Income Taxes Payable
-6.934.93.924.17.68
Upgrade
Other Current Liabilities
77.7266.3557.5978.77108.6297.15
Upgrade
Total Current Liabilities
194.9225.77166.28458.64250.27248.66
Upgrade
Long-Term Debt
110110--293.99290.57
Upgrade
Long-Term Leases
204.16245.58300.2543.0456.9470.8
Upgrade
Pension & Post-Retirement Benefits
4.574.576.345.857.77.12
Upgrade
Other Long-Term Liabilities
2.710.98----
Upgrade
Total Liabilities
516.34586.89472.87507.53608.9617.15
Upgrade
Common Stock
475.03475.64477.92475.07466.67466.67
Upgrade
Additional Paid-In Capital
256.68256.07253.78255.2263.24263.24
Upgrade
Retained Earnings
120.98264.88362.13453.37482.6545.36
Upgrade
Treasury Stock
-23.74-23.74-23.74-23.74-23.74-
Upgrade
Comprehensive Income & Other
17.8518.634.3647.5341.367.79
Upgrade
Shareholders' Equity
846.79991.451,1041,2071,2301,283
Upgrade
Total Liabilities & Equity
1,3631,5781,5771,7151,8391,900
Upgrade
Total Debt
364.64410.59354.22351.24364.63374.01
Upgrade
Net Cash (Debt)
-298.68-159.07235.7755.23738.13777.67
Upgrade
Net Cash Growth
---68.79%2.32%-5.08%194.15%
Upgrade
Net Cash Per Share
-6.47-3.455.1316.4715.8715.79
Upgrade
Filing Date Shares Outstanding
46.1446.7546.9746.6945.8546.67
Upgrade
Total Common Shares Outstanding
46.1446.7546.9746.6945.8546.67
Upgrade
Working Capital
392.76547.93817.81984.481,2821,374
Upgrade
Book Value Per Share
18.3521.2123.5125.8626.8327.49
Upgrade
Tangible Book Value
846.77991.421,1041,2071,2301,283
Upgrade
Tangible Book Value Per Share
18.3521.2123.5125.8626.8327.49
Upgrade
Land
-37.2637.2637.2637.2637.26
Upgrade
Buildings
-72.7572.7572.7572.7572.75
Upgrade
Machinery
371.32221.15221.15213.92209.29206.89
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.